X4 Pharmaceuticals
Stock Forecast, Prediction & Price Target
X4 Pharmaceuticals Financial Estimates
X4 Pharmaceuticals Revenue Estimates
X4 Pharmaceuticals EBITDA Estimates
X4 Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $48.07M Low: $8.12M High: $142.10M avg. 0% | Avg: $98.71M Low: $16.98M High: $327.03M avg. 105.33% | Avg: $177.4M Low: $30.51M High: $587.69M avg. 79.70% | Avg: $205.45M Low: $35.34M High: $680.64M avg. 15.81% |
Net Income
% change YoY
| $-88.69M N/A | $-93.86M -5.83% | $-101.16M -7.77% | Avg: $-110.35M Low: $-124.46M High: $-17.78M avg. -9.07% | Avg: $-70.62M Low: $-97.79M High: $33.78M avg. 35.99% | Avg: $-1.06M Low: $-4.27M High: $81.47K avg. 98.48% | Avg: $16.00M Low: $-1.22M High: $64.11M avg. 1600.00% |
EBITDA
% change YoY
| $-65.59M N/A | $-88.58M -35.05% | $-107.52M -21.37% | Avg: $28.84M Low: $4.87M High: $85.26M avg. 126.82% | Avg: $59.23M Low: $10.18M High: $196.22M avg. 105.33% | Avg: $106.44M Low: $18.31M High: $352.61M avg. 79.70% | Avg: $123.27M Low: $21.20M High: $408.38M avg. 15.81% |
EPS
% change YoY
| -$3.44 N/A | -$1.48 56.97% | -$0.57 61.48% | Avg: -$0.47 Low: -$0.7 High: -$0.1 avg. 18.04% | Avg: -$0.24 Low: -$0.55 High: $0.19 avg. 47.91% | Avg: -$0.01 Low: -$0.02 High: $0 avg. 97.53% | Avg: $0.09 Low: -$0.01 High: $0.36 avg. 1600% |
Operating Expenses
% change YoY
| $75.34M N/A | $88.07M 16.89% | $107.52M 22.07% | Avg: $105.58M Low: $17.85M High: $312.07M avg. -1.80% | Avg: $216.79M Low: $37.29M High: $718.22M avg. 105.33% | Avg: $389.59M Low: $67.01M High: $1.29B avg. 79.70% | Avg: $451.20M Low: $77.61M High: $1.49B avg. 15.81% |
FAQ
What is X4 Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 431.35% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -124.46M, average is -110.35M and high is -17.78M.
What is X4 Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 50.21% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $8.12M, average is $48.07M and high is $142.10M.
What is X4 Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 440.87% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$0.7, average is -$0.47 and high is $-0.1.
What is the best performing analyst?
In the last twelve months analysts have been covering X4 Pharmaceuticals stock. The most successful analyst is Edward Tenthoff.